<DOC>
	<DOCNO>NCT00000840</DOCNO>
	<brief_summary>To evaluate viral load blood stream HIV-infected patient 28-day washout follow cessation long-term zidovudine ( AZT ) therapy . Because viral load ( amount HIV RNA plasma ) often used measure effectiveness new antiretroviral drug clinical trial , washout period , cessation current antiretroviral regimen , commonly require study entry allow drug-free steady state viral load prior initiation new drug . However , kinetics viral rebound follow drug withdrawal sufficiently study , proper duration washout estimate .</brief_summary>
	<brief_title>A Multicenter , Exploratory Study Evaluate Effects Antiretroviral Cessation Plasma Associated HIV-1 RNA</brief_title>
	<detailed_description>Because viral load ( amount HIV RNA plasma ) often used measure effectiveness new antiretroviral drug clinical trial , washout period , cessation current antiretroviral regimen , commonly require study entry allow drug-free steady state viral load prior initiation new drug . However , kinetics viral rebound follow drug withdrawal sufficiently study , proper duration washout estimate . Patients volunteer temporarily cease antiretroviral therapy follow 28-day washout period . Blood sample draw nine clinic visit . Patients may resume antiretrovirals 28-day washout .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Maintenance therapy opportunistic infection , provide patient receive least 1 month stable therapy prior study . GCSF . Patients must : HIV infection . CD4 count &lt; = 500 cells/mm3 . At least 12 month prior AZT , 2 month continuous AZT monotherapy immediately prior study . The need discontinue AZT drugrelated toxicity unwanted side effect entry requirement another research study . Consent parent guardian &lt; 18 year old . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Current medical status consider unsuitable study participation . Concurrent Medication : Excluded : Therapy acute opportunistic infection . Prior Medication : Excluded within past 2 month : Antiretrovirals AZT . Systemic immunomodulators ( e.g. , gp120 , gp160 , IL2 , interferon ) . Excluded within past month : Vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2000</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Biological Markers</keyword>
	<keyword>Viremia</keyword>
	<keyword>RNA , Viral</keyword>
</DOC>